Cargando…

Side effects of drugs annual. a worldwide yearly survey of new data and trends in adverse drug reactions / 35 :

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical ye...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Aronson, J. K. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam, Netherlands ; Oxford, England : Elsevier, 2014.
Edición:First edition.
Temas:
Acceso en línea:Texto completo
Texto completo
Tabla de Contenidos:
  • Front Cover; Side Effects of Drugs Annual 35; Copyright; Contributors; Contents; Special reviews in SEDA-35; Cumulative indexes of special reviews, Annuals 4-34; Index of medications in special reviews; Index of adverse effects and adverse reactions in special reviews; Table of Essays, Annuals 1-34; Mechanistic and clinical descriptions of adverse drug reactions; EIDOS; DoTS; References; Definitive (between-the-eyes) adverse drug reactions; References; How to use this book; The scope of the Side Effects of Drugs Annuals; Period covered; Selection of material; Special reviews
  • Allocation of drugs to chaptersNames of drugs and chemicals; System of tagging references; Indexes; Abbreviations; 35 years of the Side Effects of Drugs Annuals-a tribute to our contributors; References; Classification of immunological reactions; References; Classification of drug teratogenicity; Reference; Grades of adverse drug reactions; Reference; Observational studies in assessing benefits and harms: double standards?; Selective serotonin reuptake inhibitors (SSRIs) in pregnancy; Systematic reviews and meta-analyses; Conclusions; Isotretinoin and suicide; The evidence; Conclusions
  • Paracetamol (acetaminophen) and allergic disordersInitial evidence; Further evidence; Confounding factors; Later studies; Conclusions; Other examples; Glucocorticoids and atrial fibrillation; Antipsychotic drugs and hemoglobin A1C; Proton pump inhibitors+clopidogrel; Psychoactive drugs and memory loss; Adverse reactions to methylphenidate; Conclusions; Anecdotal reports; Observational studies; Recommendations; References; Chapter 1: Central nervous system stimulants and drugs that suppress appetite; Amphetamines [SED-15, 180; SEDA-32, 1; SEDA-33, 1; SEDA-34, 1]
  • Ecstasy (3,4-methylenedioxymetamfetamine, MDMA)Metamfetamine [SEDA-32, 3; SEDA-33, 3; SEDA-34, 2]; Paramethoxyamfetamine and paramethoxymetamfetamine; Fenfluramine and analogues [SED-15, 1333; SEDA-32, 7; SEDA-33, 6; SEDA-34, 3]; Benfluorex [SEDA-34, 3]; Atomoxetine [SEDA-33, 6; SEDA-34, 4]; Methylphenidate [SED-15, 2307; SEDA-32, 10; SEDA-33, 7; SEDA-34, 5]; Modafinil and armodafinil [SED-15, 2369; SEDA-32, 6; SEDA-33, 11; SEDA-34, 6]; Methylxanthines; Caffeine [SED-15, 588; SEDA-32, 14; SEDA-33, 11; SEDA-34, 6]; Theophylline [SED-15, 3361; SEDA-32, 15]
  • Drugs That Suppress Appetite [SEDA-32, 16 SEDA-33, 13; SEDA-34, 8]; Phentermine [SED-15, 2804; SEDA-32, 17; SEDA-33, 13; SEDA-34, 8]; Rimonabant [SEDA-32, 19; SEDA-33, 13; SEDA-34, 8]; Sibutramine [SED-15, 3131; SEDA-32, 17; SEDA-33, 13; SEDA-34, 8]; Drugs Used in Alzheimers Disease [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]; Donepezil [SED-15, 1179; SEDA-32, 19; SEDA-33, 15; SEDA-34, 10]; Galantamine; Rivastigmine [SED-15, 3072; SEDA-32, 20; SEDA-33, 16; SEDA-34, 10]; References; Chapter 2: Antidepressant drugs; General